Experts Collaborate to Update Cancer Treatment Guidelines
International collaboration in oncology empowers health care workers and improves lives across various resource environments.
In a significant development, international oncology experts have gathered for a series of important meetings aimed at updating the cancer treatment recommendations in the NCCN Harmonized Guidelines™ dedicated to Sub-Saharan Africa. This initiative is part of an ongoing collaboration involving key players, including the African Cancer Coalition (ACC), the American Cancer Society (ACS), and the National Comprehensive Cancer Network (NCCN), along with the Clinton Health Access Initiative (CHAI), who collectively form the group known as Allied Against Cancer. These organizations are committed to delivering context-appropriate, evidence-based strategies for cancer care that address the unique challenges prevalent in the region.
Aligning Cancer Care with Global Standards
As cancer cases continue to rise in Sub-Saharan Africa, standardizing treatment based on the latest evidence-based recommendations is crucial. This standardization not only ensures consistency in treatment practices but also facilitates better resource planning. Dr. Henry Ddungu, a Senior Consultant in Hematology/Oncology at the African Cancer Coalition, emphasized the importance of leading with local expertise and integrating it with global best practices. He stated, "We can ensure people with cancer receive the most effective treatment by harnessing local expertise combined with global best practices."
Focus Areas of the Updated Guidelines
The meetings will specifically address updates concerning blood malignancies and cancers affecting children. The NCCN Harmonized Guidelines™ will provide detailed care recommendations for various conditions including:
- Acute Lymphoblastic Leukemia
- Acute Myeloid Leukemia
- B-cell Lymphomas
- Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
- Chronic Myeloid Leukemia
- Hodgkin Lymphoma
- Multiple Myeloma
- Pediatric Acute Lymphoblastic Leukemia
- Pediatric Aggressive B-Cell Lymphomas
- Pediatric Central Nervous System Cancers
- Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
Since the inception of Allied Against Cancer and the first publication of the NCCN Harmonized Guidelines™ in 2017, the initiative now addresses over 90% of adult cancer incidences as well as a majority of pediatric cancers. Anu Agrawal, MD, who serves as Vice President for Global Cancer Support at the ACS, expressed pride in their collaborative achievements and optimism for the continuous advancement of cancer care across the region.
Addressing Health Equity in Cancer Care
The need for health equity on a global scale drives the urgency to equip healthcare providers with optimal tools and resources tailored for diverse settings. Dr. Crystal S. Denlinger, the CEO of NCCN, noted that these guidelines are essential for helping cancer care professionals stay abreast of the latest advancements in treatment. They offer a well-structured roadmap for ideal treatment options while considering the challenges that healthcare workers face in resource-limited environments.
Dr. Denlinger was accompanied by Wui-Jin Koh, MD, NCCN's Chief Medical Officer, and prominent leaders from the NCCN Clinical Practice Guidelines in Oncology Panel. They include:
- Ranjana H. Advani, MD, Stanford Cancer Institute
- Jessica K. Altman, MD, Robert H. Lurie Comprehensive Cancer Center
- Hiroto Inaba, MD, PhD, St. Jude Children's Research Hospital
The NCCN Harmonized Guidelines™ feature a tiered recommendation system based on available medical resources, covering over 40 cancer types along with their screening and supportive care needs. The guidelines have been utilized nearly 70,000 times since their introduction and have garnered support from Federal Ministries of Health and established cancer centers across various nations.
Ongoing Efforts to Enhance Cancer Treatment
To learn more about the collaborative endeavors aimed at enhancing cancer care in Sub-Saharan Africa, interested parties can visit Allied Against Cancer's website. Moreover, additional international cancer prevention and treatment resources are available through NCCN's website.
About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network (NCCN) represents a not-for-profit alliance of leading cancer centers devoted to advancing patient care, research, and educational initiatives. NCCN is committed to improving the quality and accessibility of cancer care so patients can lead fulfilling lives. Their Clinical Practice Guidelines in Oncology are the recognized standard for cancer management policy and offer exhaustive, frequently-updated recommendations based on expert consensus.
Media Contact:
Rachel Darwin
267-622-6624
Frequently Asked Questions
What is the purpose of the updated NCCN Harmonized Guidelines?
The guidelines aim to standardize cancer treatment in Sub-Saharan Africa based on the latest evidence and expert consensus.
Who are the collaborators involved in this initiative?
The initiative includes the African Cancer Coalition, American Cancer Society, and National Comprehensive Cancer Network, among others.
What areas will the updated guidelines focus on?
The updates will primarily focus on blood malignancies and pediatric cancers, among other categories.
How many cancer types do the guidelines cover?
The NCCN Harmonized Guidelines™ cover over 40 different cancer types and provide comprehensive treatment recommendations.
Why is health equity important in cancer care?
Health equity ensures all patients have access to the best treatment options and resources, regardless of their location or circumstances.
